CSPC Pharmaceutical Group Limited Tangible Net Worth Ratio
CSPC Pharmaceutical Group Limited tangible net worth ratio. CSPC Pharmaceutical Group Limited (CVG) has a Tangible Net Worth Ratio of 92.0% as of December 2025. This metric is calculated by deducting intangible assets (€2.77 Billion) from net assets (€34.55 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check CVG strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of CSPC Pharmaceutical Group Limited (2013–2025)
Tangible net worth ratio of CSPC Pharmaceutical Group Limited from 2013 to 2025. This chart shows how CSPC Pharmaceutical Group Limited's Tangible Net Worth Ratio has changed across 13 annual periods from 2013 to 2025. As of December 2025, the ratio stands at 92.0%, reflecting net assets of €34.55 Billion with intangible assets of €2.77 Billion EUR. See CSPC Pharmaceutical Group Limited working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
CSPC Pharmaceutical Group Limited Tangible Net Worth Ratio by Year (2013–2025)
CSPC Pharmaceutical Group Limited tangible net worth ratio by year from 2013 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for CSPC Pharmaceutical Group Limited from 2013 to 2025, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see CSPC Pharmaceutical Group Limited market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 92.0% | €34.55 Billion | €2.77 Billion | €46.70 Billion | ▼ -0.3 pp |
| 2024 | 92.3% | €33.87 Billion | €2.61 Billion | €44.39 Billion | ▼ -1.4 pp |
| 2023 | 93.7% | €35.02 Billion | €2.20 Billion | €46.28 Billion | ▼ -0.2 pp |
| 2022 | 94.0% | €31.64 Billion | €1.91 Billion | €41.77 Billion | ▼ -4.3 pp |
| 2021 | 98.3% | €26.83 Billion | €467.85 Million | €34.74 Billion | ▲ +0.5 pp |
| 2020 | 97.8% | €23.10 Billion | €508.74 Million | €30.07 Billion | ▲ +3.6 pp |
| 2019 | 94.2% | €19.52 Billion | €1.14 Billion | €26.32 Billion | ▼ -0.6 pp |
| 2018 | 94.8% | €15.50 Billion | €805.39 Million | €23.17 Billion | ▼ -4.5 pp |
| 2017 | 99.3% | €12.87 Billion | €86.21 Million | €18.00 Billion | ▲ +0.1 pp |
| 2016 | 99.2% | €9.13 Billion | €70.94 Million | €13.22 Billion | ▲ +0.0 pp |
| 2015 | 99.2% | €8.81 Billion | €69.88 Million | €13.54 Billion | ▲ +0.2 pp |
| 2014 | 99.0% | €8.15 Billion | €84.12 Million | €12.50 Billion | ▲ +0.2 pp |
| 2013 | 98.7% | €7.60 Billion | €96.26 Million | €12.20 Billion | — |